David Spiegel

Stanford University — United States

Medicine · Health Sciences

111h-index46.6kcitations880works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer survivorship and care(172), Pain Management and Placebo Effect(140), Psychosomatic Disorders and Their Treatments(124), Childhood Cancer Survivors' Quality of Life(101), Family Support in Illness(88)

Publications875 total

Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an <scp>EEG</scp> study providing insight into mechanism of action and a potentially predictive biomarker of efficacy
World Psychiatry·2026· 2 citedOpen Access
The Emergency Department and Psychiatric Boarding: A Model for the Future: 2026 Update
Clinical Neuropharmacology·2025
Effects of app delivered self hypnosis on stress management
npj Digital Medicine·2025Open Access
Secondary Trigeminal Neuralgia Due to Multiple Sclerosis in a Patient With Opioid Use Disorder Treated With Buprenorphine/Naloxone
The Primary Care Companion For CNS Disorders·2025
Moby Dick Supports an Ethological Model of Social Behavior, Socio-Cognition and Social Communication: Do von Economo-like Neurons Play a Role?
Clinical Neuropharmacology·2025
Social media impact and smartwatch monitoring: Prevalence and early markers of PTSD and anxiety following mass traumatic events
PLOS mental health.·2025Open Access
Treatment of Refractory Bipolar Depression With Stereotactic Radiosurgery Targeting the Subgenual Cingulate Cortex
Cureus·2025Open Access
Site-Specific Associations between NCCN Distress Thermometer Screening Data and NLP-Identified Toxicities during Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2025
The Roles of Gender and Patient Versus Caregiver Status in Cardiovascular and Affective Responses to an Induced Stress
Biopsychosocial Science and Medicine·2025· 1 cited
Supplementary Table S2 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S6 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S7 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S4 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Figure S1 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S3 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S1 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplementary Table S5 from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Supplemental Methods from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
Data from Incidence of Depression and Anxiety in Kidney Cancer Survivors: A Nationwide Population-Based Cohort Study
2025Open Access
0004 Melatonin–sleep Phase Angle Predicts Mortality in Women with Advanced Breast Cancer
SLEEP·2025Open Access
page 1 of 44Next →

Frequent Co-authors

Cheryl Koopman(9), Janine Giese‐Davis(8), Helena C. Kraemer(6), Etzel Cardeña(5), Catherine Classen(5), Sandra E. Sephton(4), Eric Vermetten(3), Richard J. Loewenstein(3), Bethany L. Brand(3), Bita Nouriani(3), Lisa D. Butler(3), Sue Dimiceli(3), Matthew J. Friedman(3), Eric Neri(3), Joan R. Bloom(3), Ruth A. Lanius(2), J. Douglas Bremner(2), Dwight L. Evans(2), Robert M. Carney(2), Mahlon R. DeLong(2)